Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure

Bernadet T. Santema, Michelle M. Y. Chan, Jasper Tromp, Martin Dokter, Haye H. van der Wal, Johanna E. Emmens, Janny Takens, Nilesh J. Samani, Leong L. Ng, Chim C. Lang, Peter van der Meer, Jozine M. Ter Maaten, Kevin Damman, Kenneth Dickstein, John G. Cleland, Faiez Zannad, Stefan D. Anker, Marco Metra, Pim van der Harst, Rudolf A. de BoerDirk J. van Veldhuisen, Michiel Rienstra, Carolyn S. P. Lam, Adriaan A. Voors

Research output: Contribution to journalArticlepeer-review

8 Downloads (Pure)

Abstract

The original version of this article unfortunately contained a mistake. Section “Results”, second paragraph, first sentence should read: The plasma levels of NT-proBNP were significantly higher in patients who had AF at baseline, with a median of 3417 pg/mL (1897–6486), as compared with patients who were in SR at baseline; both those who had a history of AF (1788 pg/mL [682–3870], p < 0.001) and those who never had AF before (2231 pg/mL [902–5270], p < 0.001) (Table 1), also after multivariable adjustment (Table 2).

Original languageEnglish
Number of pages1
JournalClinical Research in Cardiology
DOIs
Publication statusE-pub ahead of print - 3 Nov 2020

Fingerprint Dive into the research topics of 'Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure'. Together they form a unique fingerprint.

Cite this